Minerva Neurosciences (NERV) Assets Average (2014 - 2026)

Minerva Neurosciences (NERV) has 13 years of Assets Average data on file, last reported at $96.0 million in Q1 2026.

• Quarterly Assets Average rose 174.51% year-over-year to $96.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.0 million (up 174.51% YoY) and the FY2025 annual result came in at $67.6 million, up 43.67% from the prior year.
• Assets Average improved to $96.0 million in Q1 2026, from $63.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $96.0 million in Q1 2026 to a low of $29.3 million in Q3 2025.
• A 5-year average of $55.3 million and a median of $57.4 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average plunged 38.53% — and 2026, when it surged 174.51%.
• Tracing NERV's Assets Average over 5 years: stood at $57.4 million in 2022, then rose by 4.51% to $60.0 million in 2023, then plunged by 33.39% to $40.0 million in 2024, then soared by 57.66% to $63.0 million in 2025, then soared by 52.3% to $96.0 million in 2026.
• The last three Assets Average figures came in at $96.0 million (Q1 2026), $63.0 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.